Xuriden Recall

Get an alert when a recall is issued.

Questions & Answers

Side Effects & Adverse Reactions

There is currently no warning information available for this product. We apologize for any inconvenience.

Legal Issues

There is currently no legal information available for this drug.

FDA Safety Alerts

There are currently no FDA safety alerts available for this drug.

Manufacturer Warnings

There is currently no manufacturer warning information available for this drug.

FDA Labeling Changes

There are currently no FDA labeling changes available for this drug.


XURIDEN™ is a pyrimidine analog indicated for uridine replacement in patients with hereditary orotic aciduria.


There is currently no drug history available for this drug.

Other Information

XURIDEN (uridine triacetate) oral granules is a pyrimidine analog containing uridine triacetate. Uridine triacetate has the chemical designation (2',3',5'-tri-O-acetyl-ß-D-ribofuranosyl)-2,4(1H,3H)-pyrimidinedione. The molecular weight is 370.3 and it has an empirical formula of C15H18N2O9. The structural formula is:

Chemical Structure

Each single-use 2 gram packet of XURIDEN orange-flavored oral granules (95% w/w) contains 2 grams of uridine triacetate and the following inactive ingredients: ethylcellulose (0.062 grams), Opadry Clear [proprietary dispersion of hydroxypropylmethylcellulose and Macrogol] (0.015 grams), and natural orange juice flavor (0.026 grams).

Xuriden Manufacturers

  • Wellstat Therapeutics Corporation
    Xuriden (Uridine Triacetate) Granule [Wellstat Therapeutics Corporation]

Login To Your Free Account